Eton Pharmaceuticals Investor Relations Material
Latest events
Q4 2023
Eton Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Eton Pharmaceuticals Inc
Access all reports
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. Its lead product candidate is Etonogestrel/Ethinyl Estradiol (ETN/EE) Vaginal Contraceptive System (VCS), an FDA approved Class 4 non-biodegradable contraceptive vaginal ring for the treatment of female contraception. The company was founded in 2013 and is based in Bloomingdale, Illinois.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States